Mirati Therapeutics Inc. diskutieren
Mirati Therapeutics Inc.
WKN: A1W1XV / Symbol: MRTX / Name: Mirati / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
53,84 €
-0,04 %
Buy Mirati Therapeutics Inc.
Mirati Therapeutics, Inc. (NASDAQ: MRTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $83.00 price target on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Mirati Therapeutics, Inc. (NASDAQ: MRTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for MRTX provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in American Airlines Group Inc. diskutieren